<?xml version="1.0" encoding="UTF-8" standalone="no"?>

<MINiML
   xmlns="http://www.ncbi.nlm.nih.gov/geo/info/MINiML"
   xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
   xsi:schemaLocation="http://www.ncbi.nlm.nih.gov/geo/info/MINiML http://www.ncbi.nlm.nih.gov/geo/info/MINiML.xsd"
   version="0.5.0" >

  <Contributor iid="contrib1">
    <Person><First>Peter</First><Last>Bross</Last></Person>
    <Email>peter.bross@ki.au.dk</Email>
    <Phone>+4589495147</Phone>
    <Fax>+4589496018</Fax>
    <Laboratory>Research Unit for Molecular Medicine</Laboratory>
    <Department>Institute for Clinical Medicine</Department>
    <Organization>Aarhus University Hospital, Skejby</Organization>
    <Address>
      <Line>Brendstrupgaardsvej 100</Line>
      <City>Århus</City>
      <Postal-Code>8200</Postal-Code>
      <Country>Denmark</Country>
    </Address>
  </Contributor>

  <Contributor iid="contrib2">
    <Organization></Organization>
    <Email>geo@ncbi.nlm.nih.gov, support@affymetrix.com</Email>
    <Phone>888-362-2447</Phone>
    <Organization>Affymetrix, Inc.</Organization>
    <Address>
      <City>Santa Clara</City>
      <State>CA</State>
      <Zip-Code>95051</Zip-Code>
      <Country>USA</Country>
    </Address>
    <Web-Link>http://www.affymetrix.com/index.affx</Web-Link>
  </Contributor>

  <Contributor iid="contrib3">
    <Person><First>Søren</First><Last>Naundrup</Last></Person>
  </Contributor>

  <Contributor iid="contrib4">
    <Person><First>Jakob</First><Last>Hansen</Last></Person>
  </Contributor>

  <Contributor iid="contrib5">
    <Person><First>Marit</First><Middle>N</Middle><Last>Nielsen</Last></Person>
  </Contributor>

  <Contributor iid="contrib6">
    <Person><First>Jane</First><Middle>H</Middle><Last>Christensen</Last></Person>
  </Contributor>

  <Contributor iid="contrib7">
    <Person><First>Mogens</First><Last>Kruhøffer</Last></Person>
  </Contributor>

  <Contributor iid="contrib8">
    <Person><First>Johan</First><Last>Palmfeldt</Last></Person>
  </Contributor>

  <Contributor iid="contrib9">
    <Person><First>Thomas</First><Middle>J</Middle><Last>Corydon</Last></Person>
  </Contributor>

  <Contributor iid="contrib10">
    <Person><First>Debbie</First><Last>Ang</Last></Person>
  </Contributor>

  <Contributor iid="contrib11">
    <Person><First>Costa</First><Last>Georgopoulos</Last></Person>
  </Contributor>

  <Contributor iid="contrib12">
    <Person><First>Niels</First><Last>Gregersen</Last></Person>
  </Contributor>

  <Contributor iid="contrib13">
    <Person><First>Kåre</First><Middle>L</Middle><Last>Nielsen</Last></Person>
  </Contributor>

  <Database iid="GEO">
    <Name>Gene Expression Omnibus (GEO)</Name>
    <Public-ID>GEO</Public-ID>
    <Organization>NCBI NLM NIH</Organization>
    <Web-Link>http://www.ncbi.nlm.nih.gov/geo</Web-Link>
    <Email>geo@ncbi.nlm.nih.gov</Email>
  </Database>

  <Platform iid="GPL199">
    <Status database="GEO">
      <Submission-Date>2002-07-01</Submission-Date>
      <Release-Date>2002-07-18</Release-Date>
      <Last-Update-Date>2010-07-08</Last-Update-Date>
    </Status>
    <Title>[Ecoli_ASv2] Affymetrix E. coli Antisense Genome Array</Title>
    <Accession database="GEO">GPL199</Accession>
    <Technology>in situ oligonucleotide</Technology>
    <Distribution>commercial</Distribution>
    <Organism taxid="83333">Escherichia coli K-12</Organism>
    <Manufacturer>Affymetrix</Manufacturer>
    <Manufacture-Protocol>
see manufacturer's web site
    </Manufacture-Protocol>
    <Description>
Affymetrix submissions are typically submitted to GEO using the GEOarchive method described at http://www.ncbi.nlm.nih.gov/projects/geo/info/geo_affy.html

Has 7312 entries and was indexed 20-May-2002.
The GeneChip E. coli Antisense Genome Array can be used for examining expression of all known E. coli genes and discovering novel, uncharacterized intergenic transcripts. The array contains probe sets to detect the antisense strand of more than 4,200 known open reading frames. In addition, over 1,350 intergenic sequences can be interrogated in both directions permitting functional characterization of potentially important shorter expressed sequences.
Sequence information for probes on the array correspond to the M49 version of the E. coli Genome Project database at the University of Wisconsin.


Keywords = high density oligonucleotide array
    </Description>
    <Web-Link>http://www.affymetrix.com/support/technical/byproduct.affx?product=ecoliantisense</Web-Link>
    <Web-Link>http://www.affymetrix.com/analysis/index.affx</Web-Link>
    <Relation type="Alternative to" target="GPL10659" comment="Alternative CDF" />
    <Data-Table>
      <Column position="1">
        <Name>ID</Name>
        <Description>Affymetrix Probe Set ID </Description>
        <Link-Prefix>https://www.affymetrix.com/LinkServlet?array=ECOLI_ANTISENSE&amp;probeset=</Link-Prefix>
      </Column>
      <Column position="2">
        <Name>ORF</Name>
        <Description>Locus tag  </Description>
        <Link-Prefix>http://www.ncbi.nlm.nih.gov/sites/entrez?db=gene&amp;cmd=search&amp;term=</Link-Prefix>
        <Link-Suffix>[gene name] AND Escherichia coli K12[organism]</Link-Suffix>
      </Column>
      <Column position="3">
        <Name>SPOT_ID</Name>
      </Column>
      <Column position="4">
        <Name>Species Scientific Name</Name>
        <Description>The genus and species of the organism represented by the probe set.</Description>
      </Column>
      <Column position="5">
        <Name>Annotation Date</Name>
        <Description>The date that the annotations for this probe array were last updated. It will generally be earlier than the date when the annotations were posted on the Affymetrix web site.</Description>
      </Column>
      <Column position="6">
        <Name>Sequence Type</Name>
        <Description>Indicates whether the sequence is an Exemplar, Consensus or Control sequence. An Exemplar is a single nucleotide sequence taken directly from a public database. This sequence could be an mRNA or EST. A Consensus sequence, is a nucleotide sequence assembled by Affymetrix, based on one or more sequence taken from a public database.</Description>
      </Column>
      <Column position="7">
        <Name>Representative Public ID</Name>
        <Description>The accession number of a representative sequence. Note that for consensus-based probe sets, the representative sequence is only one of several sequences (sequence sub-clusters) used to build the consensus sequence and it is not directly used to derive the probe sequences. The representative sequence is chosen during array design as a sequence that is best associated with the transcribed region being interrogated by the probe set. Refer to the &quot;Sequence Source&quot; field to determine the database used.</Description>
      </Column>
      <Column position="8">
        <Name>Sequence Source</Name>
        <Description>The database from which the sequence used to design this probe set was taken.</Description>
      </Column>
      <Column position="9">
        <Name>Target Description</Name>
        <Description>GenBank description associated with the representative public identifier. Blank for some probe sets.</Description>
      </Column>
      <Column position="10">
        <Name>Gene Title</Name>
        <Description>Title of Gene represented by the probe set.</Description>
      </Column>
      <Column position="11">
        <Name>Gene Symbol</Name>
        <Description>A gene symbol, when one is available (from UniGene).</Description>
      </Column>
      <Column position="12">
        <Name>ENTREZ_GENE_ID</Name>
        <Description>Entrez Gene Database UID  </Description>
        <Link-Prefix>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&amp;cmd=Retrieve&amp;dopt=Graphics&amp;list_uids=</Link-Prefix>
        <Link-Delimiter> /// </Link-Delimiter>
      </Column>
      <Column position="13">
        <Name>RefSeq Transcript ID</Name>
        <Description>References to multiple sequences in RefSeq. The field contains the ID and Description for each entry, and there can be multiple entries per ProbeSet.</Description>
      </Column>
      <Column position="14">
        <Name>Gene Ontology Biological Process</Name>
        <Description>Gene Ontology Consortium Biological Process derived from LocusLink.  Each annotation consists of three parts: &quot;Accession Number // Description // Evidence&quot;. The description corresponds directly to the GO ID. The evidence can be &quot;direct&quot;, or &quot;extended&quot;.</Description>
      </Column>
      <Column position="15">
        <Name>Gene Ontology Cellular Component</Name>
        <Description>Gene Ontology Consortium Cellular Component derived from LocusLink.  Each annotation consists of three parts: &quot;Accession Number // Description // Evidence&quot;. The description corresponds directly to the GO ID. The evidence can be &quot;direct&quot;, or &quot;extended&quot;.</Description>
      </Column>
      <Column position="16">
        <Name>Gene Ontology Molecular Function</Name>
        <Description>Gene Ontology Consortium Molecular Function derived from LocusLink.  Each annotation consists of three parts: &quot;Accession Number // Description // Evidence&quot;. The description corresponds directly to the GO ID. The evidence can be &quot;direct&quot;, or &quot;extended&quot;.</Description>
      </Column>
    <External-Data rows="7312">
GPL199-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Platform>

  <Sample iid="GSM277818">
    <Status database="GEO">
      <Submission-Date>2008-03-28</Submission-Date>
      <Release-Date>2008-04-14</Release-Date>
      <Last-Update-Date>2008-04-14</Last-Update-Date>
    </Status>
    <Title>E.coli/Hsp60-wt/wt(-/+)</Title>
    <Accession database="GEO">GSM277818</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>E. coli B178 groESL(-) expressing human Hsp60 and Hsp10</Source>
      <Organism taxid="562">Escherichia coli</Organism>
      <Characteristics tag="E. coli strain B178 (Georgopoulos et al. (1973) J Mol Biol 76">
45-60) in which the endogenous groES and groEL genes have been deleted and that is maintained alive by the pOFX-tac1-derived plasmid carrying an IPTG-inducible operon with cDNA encoding human Hsp10 and the mature part of human wild type Hsp60 (Hansen et al., 2002). These cells were subsequently transformed by electroporation with a second plasmid, derivative of pBAD/hisA (Invitrogen), that contained an operon with Hsp10 and wild type Hsp60 under control of the arabinose-inducible BAD promoter. The pBAD/hisA-derived plasmids carry a pBR322 origin of replication and an ampicillin resistance gene and can be stably maintained in the same cell with the p15A-origin/kanamycin resistance gene containing pOFX-tac derivative.
      </Characteristics>
      <Growth-Protocol>
Bacterial cells were grown in dYT medium (Miller, JH (1972) Experiments in Molecular Genetics (Cold Spring Harbor Laboratory, Cold Spring Harbor, NY) supplemented with kanamycin (10 mg/L), ampicillin (100 mg/L) and IPTG (0.1mM) at 30°C in a shaking water bath. At a turbidity (measured at OD536) of approximately 0.1 bacteria were harvested by centrifugation at ambient temperature and resuspended in fresh dYT medium containing antibiotics and 0.2% arabinose. Growth was continued at 30°C and 10 hours after inducer shift 3ml sample were withdrawn, treated with RNAPROTECT (Qiagen, Ballerup), harvested by centrifugation and frozen.
      </Growth-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was purified using the RNAeasy kit (Qiagen).
      </Extract-Protocol>
      <Label>phycoerythrin</Label>
      <Label-Protocol>
Affymetrix standard
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Affymetrix standard
    </Hybridization-Protocol>
    <Scan-Protocol>
Affymetrix standard
    </Scan-Protocol>
    <Description>
Isolated RNA from 2 parallel cultures originating from 2 individual transformants was pooled and used for cDNA synthesis and labelling.
    </Description>
    <Data-Processing>
MAS5.0
    </Data-Processing>
    <Platform-Ref ref="GPL199" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM277nnn/GSM277818/GSM277818.CEL.gz
    </Supplementary-Data>
    <Supplementary-Data type="CHP">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM277nnn/GSM277818/GSM277818.CHP.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>MAS5 flourescence signal</Description>
      </Column>
      <Column position="3">
        <Name>ABS_CALL</Name>
        <Description>MAS5 Detection Call</Description>
      </Column>
      <Column position="4">
        <Name>DETECTION P-VALUE</Name>
        <Description>MAS5 Detection p-value</Description>
      </Column>
    <External-Data rows="7312">
GSM277818-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM277819">
    <Status database="GEO">
      <Submission-Date>2008-03-28</Submission-Date>
      <Release-Date>2008-04-14</Release-Date>
      <Last-Update-Date>2008-04-14</Last-Update-Date>
    </Status>
    <Title>E.coli/Hsp60-wt/VAL98Ile(-/+)</Title>
    <Accession database="GEO">GSM277819</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>E. coli B178 groESL(-) expressing human wt and Val98Ile Hsp60 and Hsp10</Source>
      <Organism taxid="562">Escherichia coli</Organism>
      <Characteristics tag="E. coli strain B178 (Georgopoulos et al. (1973) J Mol Biol 76">
45-60) in which the endogenous groES and groEL genes have been deleted and that is maintained alive by the pOFX-tac1-derived plasmid carrying an IPTG-inducible operon with cDNA encoding human Hsp10 and the mature part of human wild type Hsp60 (Hansen et al., 2002). These cells were subsequently transformed by electroporation with a second plasmid, derivative of pBAD/hisA (Invitrogen), that contained an operon with Hsp10 and the Val98Ile mutant variant of Hsp60 under control of the arabinose-inducible BAD promoter. The pBAD/hisA-derived plasmid carries a pBR322 origin of replication and an ampicillin resistance gene and can be stably maintained in the same cell with the p15A-origin/kanamycin resistance gene containing pOFX-tac derivative.
      </Characteristics>
      <Growth-Protocol>
Bacterial cells were grown in dYT medium (Miller, JH (1972) Experiments in Molecular Genetics (Cold Spring Harbor Laboratory, Cold Spring Harbor, NY) supplemented with kanamycin (10 mg/L), ampicillin (100 mg/L) and IPTG (0.1mM) at 30°C in a shaking water bath. At a turbidity (measured at OD536) of approximately 0.1 bacteria were harvested by centrifugation at ambient temperature and resuspended in fresh dYT medium containing antibiotics and 0.2% arabinose. Growth was continued at 30°C and 10 hours after inducer shift 3ml sample were withdrawn, treated with RNAPROTECT (Qiagen, Ballerup), harvested by centrifugation and frozen.
      </Growth-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was purified using the RNAeasy kit (Qiagen).
      </Extract-Protocol>
      <Label>phycoerythrin</Label>
      <Label-Protocol>
Affymetrix standard
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Affymetrix standard
    </Hybridization-Protocol>
    <Scan-Protocol>
Affymetrix standard
    </Scan-Protocol>
    <Description>
Isolated RNA from 3 parallel cultures originating from 3 individual transformants was pooled and used for cDNA synthesis and labelling.
    </Description>
    <Data-Processing>
MAS5.0
    </Data-Processing>
    <Platform-Ref ref="GPL199" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM277nnn/GSM277819/GSM277819.CEL.gz
    </Supplementary-Data>
    <Supplementary-Data type="CHP">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM277nnn/GSM277819/GSM277819.CHP.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>MAS5 flourescence signal</Description>
      </Column>
      <Column position="3">
        <Name>ABS_CALL</Name>
        <Description>MAS5 Detection Call</Description>
      </Column>
      <Column position="4">
        <Name>DETECTION P-VALUE</Name>
        <Description>MAS5 Detection p-value</Description>
      </Column>
    <External-Data rows="7312">
GSM277819-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Series iid="GSE10974">
    <Status database="GEO">
      <Submission-Date>2008-03-28</Submission-Date>
      <Release-Date>2008-04-14</Release-Date>
      <Last-Update-Date>2012-03-19</Last-Update-Date>
    </Status>
    <Title>Expression profiles of E. coli groESL(-) cells expressing human Hsp60(wt)/Hsp10 or Hsp60-(p.Val98Ile)/Hsp10 operons</Title>
    <Accession database="GEO">GSE10974</Accession>
    <Pubmed-ID>18400758</Pubmed-ID>
    <Summary>
To identify regulatory responses that could give clues as to the cause(s) of the growth arrest observed in E. coli cells expressing mutant Hsp60-(p.Val98Ile) and Hsp10 versus cells expressing wild type Hsp60 and Hsp10, we performed microarray analyses. We reasoned that the decreased chaperonin activity of the Hsp60-(p.Val98Ile) protein would greatly impair or abolish folding of E. coli proteins that depend on chaperonin assistance. The resulting decreased levels of various activities may cause compensatory up-regulation or deregulation of genes. The transcriptomes of cells shifted to expression of the arabinose-inducible chaperonin operon with either the Hsp60-(p.Val98Ile) mutant or the wild type Hsp60 from the second plasmid were compared. RNA samples from three independent cultures expressing the mutant or two independent cultures expressing wild type Hsp60 were pooled, respectively. 
Keywords: Comparison of cells expressing two different variants of Hsp60
    </Summary>
    <Overall-Design>
B178 (groELS)-deleted cells double-transformed with two plasmids harboring an IPTG-inducible operon with wild type human Hsp60 and Hsp10 and a second plasmid harboring an arabinose inducible operon with either Hsp60-(p.Val98Ile) and Hsp10 (mutant cells) or wild type Hsp60 and Hsp10 (wild type cells) were grown in dYT medium (21) supplemented with kanamycin (10 mg/L), ampicillin (100 mg/L) and IPTG (0.1mM) at 30°C in a shaking water bath. At OD536 ≈ 0.1 bacteria were harvested by centrifugation at ambient temperature, resuspended in fresh medium, and 0.2% arabinose was added. Growth was continued at 30°C. After 10 hours 3ml samples were withdrawn and RNA was isolated. 
Two independent transformant clones of the wild type cells and three of the mutant cells were grown in this way. The RNA preps from the 2 wild type and the three mutant cells, respectively, were pooled, cDNA was synthesized, labelled and subjected to Affymetrix arrays.
    </Overall-Design>
    <Type>Expression profiling by array</Type>
    <Contributor-Ref ref="contrib1" position="1" />
    <Contributor-Ref ref="contrib3" position="2" />
    <Contributor-Ref ref="contrib4" position="3" />
    <Contributor-Ref ref="contrib5" position="4" />
    <Contributor-Ref ref="contrib6" position="5" />
    <Contributor-Ref ref="contrib7" position="6" />
    <Contributor-Ref ref="contrib8" position="7" />
    <Contributor-Ref ref="contrib9" position="8" />
    <Contributor-Ref ref="contrib10" position="9" />
    <Contributor-Ref ref="contrib11" position="10" />
    <Contributor-Ref ref="contrib12" position="11" />
    <Contributor-Ref ref="contrib13" position="12" />
    <Contact-Ref ref="contrib1" />
    <Sample-Ref ref="GSM277818" />
    <Sample-Ref ref="GSM277819" />
    <Supplementary-Data type="TAR">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/series/GSE10974/GSE10974_RAW.tar
    </Supplementary-Data>
    <Relation type="BioProject" target="http://www.ncbi.nlm.nih.gov/bioproject/107175" />
  </Series>

</MINiML>
